Company Overview of University of California, Davis
University of California, Davis operates as an educational and research institution that offers bachelor's, master's, doctoral, first professional, and post bachelor’s degrees. It includes the College of Agricultural and Environmental Sciences, College of Engineering, College of Letters and Science and its professional schools include the Graduate School of Management, School of Education, School of Law, School of Medicine, School of Veterinary Medicine, and the Veterinary Medical Teaching Hospital. University of California - Davis was founded in 1905 and is based in Davis, California. University of California, Davis operates as a subsidiary of University of California System.
One Shields Avenue
Davis, CA 95616
Founded in 1905
Key Executives for University of California, Davis
Interim Provost & Executive Vice Chancellor
Director of Foundation Plant Services, Viticulture Consortium West, and California Competitive Grants for Research in Viticulture and Enology; and Specialist in Cooperative Extension
Compensation as of Fiscal Year 2015.
University of California, Davis Key Developments
New York Blood Center Announces New Collaboration with the University of California, Davis to Manufacture Specialized Lines of Stem Cells
Aug 20 15
New York Blood Center (NYBC) announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease. Under the two-year agreement, UC Davis will produce induced pluripotent stem cells (iPSCs) from homozygous units from New York Blood Center's umbilical cord blood bank. Cord blood units contain adult stem cells collected from umbilical cord blood donations after the birth and safe delivery of a baby. NYBC's rare collection of homozygous units presents a unique opportunity to make iPSC lines that will be capable of making any human tissue and being matched to a large number of people. This will allow for vast new opportunities for future clinical use.
University of California, Davis Presents at Macquarie Global Quantative Research Conference, Jul-22-2015 09:00 AM
Jul 20 15
University of California, Davis Presents at Macquarie Global Quantative Research Conference, Jul-22-2015 09:00 AM. Venue: Hong Kong. Speakers: Roger Edelen, Associate Professor, Graduate School of Management.
OncoSec Medical and University of California, Davis Collaborate to Test Intratumoral Cancer Immunotherapy in Canine Soft Tissue Sarcoma
Jun 1 15
OncoSec Medical Inc. announced a collaboration with University of California, Davis (UC Davis) School of Veterinary Medicine to test ImmunoPulse™ IL-12 as an immunotherapy in dogs with soft tissue sarcoma. The primary goals of the canine study are to advance the understanding of the mechanism of action of ImmunoPulse™ IL-12 and validate key clinical biomarkers. The study is an open label, neoadjuvant two-arm pilot trial in approximately 12 canines with soft tissue sarcoma. Eligible canine patients will be randomized to receive one of the two experimental ImmunoPulse™ IL-12 treatment schedules, followed by definitive surgical resection of the tumor. OncoSec's core immunotherapy platform, ImmunoPulse™, has been used to deliver DNA-based IL-12 in Phase II clinical trials for metastatic melanoma and Merkel cell carcinoma and plans to initiate Phase II studies in head and neck cancer and triple negative breast cancer.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|